CD (Suzhou) Biopharma Announces FDA Clearance for Phase I Clinical Trial of CD-001 ...Middle East

SUZHOU, China, Sept. 20, 2024 /PRNewswire/ -- CD (Suzhou) Biopharma has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application of CD-001, entering a Phase I first-in-human trial. CD-001, the company's leading clinical...

Hence then, the article about cd suzhou biopharma announces fda clearance for phase i clinical trial of cd 001 was published today ( Friday 20/09/2024 - 11:33 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CD (Suzhou) Biopharma Announces FDA Clearance for Phase I Clinical Trial of CD-001 )

Also on site :

• Die Phygital Contenders Astana 2026 gehen mit neuen Champions zu Ende - Qualifikationsrunden für die Games of the Future 2026 bestätigt
• Persistent annonce un partenariat avec les San Francisco Unicorns en tant que partenaire officiel de l'initiative Re(AI)magining™
• Football upstages politics as Iranians rally behind their team at World Cup